Yeah have to agree that cup and handle pattern does not seem to be playing out - handle has retraced too far.
However double bottom pattern still in play. This looks quite likely with the amount of support at 11c.
Just needs a good announcement to start the reversal.
Hopefully one of the 3 main tactical priorities mentioned in the latest letter to shareholders:
• Partnering lead clinical program ‐ BIT225 for HIV‐1 eradication • Partnering one or more preclinical programs – e.g. HBV • Execute a regional licensing deal in China ‐ HCV program remains akey potential opportunity
BIT Price at posting:
11.5¢ Sentiment: Buy Disclosure: Held
